# D2560C00015 FluMist Annual Safety Study 2018

> **NCT03564444** · PHASE4 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 300 (actual)

## Conditions studied

- Influenza
- Healthy

## Interventions

- **BIOLOGICAL:** Bivalent influenza vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03564444
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-06
- **Primary completion:** 2018-12-27
- **Final completion:** 2018-12-27
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03564444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03564444, "D2560C00015 FluMist Annual Safety Study 2018". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT03564444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*